Duration of Major Depressive Episode With or Without Psychotic Features and Clinical Outcomes in Electroconvulsive Therapy

OBJECTIVES: Longer duration of depressive episode in major depressive disorder has been associated with poorer clinical outcomes and decreased likelihood of treatment response. Whether this is independent of the level of medication resistance is unclear. We examined the hypothesis that longer duration of depressive episode reduces the probability of response and remission following ECT, after controlling for medication resistance and other relevant covariates. METHODS: Data were collated from 4 previously conducted ECT clinical trials. Outcomes included change in Hamilton Depression Rating Scale (24-item HDRS), response (≥50% improvement on HDRS or score of 1 or 2 on the Clinician Global Impression of Improvement Scale [CGI-I; somewhat or greatly improved]), and remission (HDRS≤10). Duration of current depressive episode was measured in weeks. Regression models were used to evaluate the effect of duration of depressive episode on depressive symptoms (linear) and response/remission (logistic). Models were adjusted for sex, age, number of failed antidepressant trials, the presence of psychotic features, and other relevant clinical and demographic factors. RESULTS: After adjusting for relevant covariates, neither the duration of the depressive episode nor the presence of psychotic features was meaningfully associated with poorer clinical outcomes following ECT. This finding remained consistent in the subgroup of patients with psychotic depression. In contrast, medication resistance was associated with higher post-ECT depressive severity, as measured by HDRS (b=3.26, 95% CI: 0.29-6.22, P=0.032). However, ECT strength (b=-8.08, 95% CI: -10.44 to -5.71, P<0.001) was strongly associated with better ECT outcomes. CONCLUSIONS: Medication resistance, and not duration of depressive episode, portends worse clinical outcomes following ECT, including in patients with psychotic depression.

Authors

Institutions

Publication Details

Journal
Journal of Ect
Published
2026-11-16
DOI
https://doi.org/10.1097/yct.0000000000001349
Primary Topic
Electroconvulsive Therapy Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Duration of Major Depressive Episode With or Without Psychotic Features and Clinical Outcomes in Electroconvulsive Therapy

Samuel T. Wilkinson, Harold A. Sackeim, Morgan Hardy, Dylan J Rhodes et al.
Journal of Ect
Electroconvulsive Therapy Studies
article

Duration of Major Depressive Episode With or Without Psychotic Features and Clinical Outcomes in Electroconvulsive Therapy

Samuel T. Wilkinson, Harold A. Sackeim, Morgan Hardy, Dylan J Rhodes, Taeho Greg Rhee
article en

Abstract

OBJECTIVES: Longer duration of depressive episode in major depressive disorder has been associated with poorer clinical outcomes and decreased likelihood of treatment response. Whether this is independent of the level of medication resistance is unclear. We examined the hypothesis that longer duration of depressive episode reduces the probability of response and remission following ECT, after controlling for medication resistance and other relevant covariates. METHODS: Data were collated from 4 previously conducted ECT clinical trials. Outcomes included change in Hamilton Depression Rating Scale (24-item HDRS), response (≥50% improvement on HDRS or score of 1 or 2 on the Clinician Global Impression of Improvement Scale [CGI-I; somewhat or greatly improved]), and remission (HDRS≤10). Duration of current depressive episode was measured in weeks. Regression models were used to evaluate the effect of duration of depressive episode on depressive symptoms (linear) and response/remission (logistic). Models were adjusted for sex, age, number of failed antidepressant trials, the presence of psychotic features, and other relevant clinical and demographic factors. RESULTS: After adjusting for relevant covariates, neither the duration of the depressive episode nor the presence of psychotic features was meaningfully associated with poorer clinical outcomes following ECT. This finding remained consistent in the subgroup of patients with psychotic depression. In contrast, medication resistance was associated with higher post-ECT depressive severity, as measured by HDRS (b=3.26, 95% CI: 0.29-6.22, P=0.032). However, ECT strength (b=-8.08, 95% CI: -10.44 to -5.71, P<0.001) was strongly associated with better ECT outcomes. CONCLUSIONS: Medication resistance, and not duration of depressive episode, portends worse clinical outcomes following ECT, including in patients with psychotic depression.

Journal of Ect
University of Connecticut (US), Medical University of South Carolina (US), Yale University (US), UConn Health (US)
Good health and well-being
Electroconvulsive Therapy Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon